Search Results
Apr 17, 2026, 06:00 ET Harbinger Health Presents Multiple Studies at AACR Reinforcing Platform Foundation for RESOLVE™, a New Category for Cancer Detection
extract tumor signal from cell-free DNADate/Time: Tuesday, April 21, 2026, at 2:00pm PTKey Takeaways:Harbinger developed a deep learning framework that analyzes methylation patterns at the resolution of individual DNA fragments, capturing tumor signal
More news about: Harbinger Health
Apr 16, 2026, 16:01 ET Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that
More news about: Acurx Pharmaceuticals, Inc.
Apr 16, 2026, 14:25 ET How IBM Quantum is Enabling Healthcare and Biology Research
whole genome onto a quantum computer is a world first and represents at least one order of magnitude improvement over any other efforts to represent DNA on quantum machines," said James McCafferty, Chief Information Officer at the Wellcome Sanger Institute. "And full credit goes to IBM in helping
More news about: IBM
Apr 16, 2026, 11:57 ET Legacy Launches $145 Clinical Semen Analysis, Setting New Price Benchmark
diagnostic value.Expanding access to sperm DNA fragmentation testingIn another move that improves affordability of male fertility care, Legacy clinician partners and patients can now access Advanced Semen Analysis, which includes DNA fragmentation testing, for just $495.This
More news about: Give Legacy, Inc.
Apr 16, 2026, 11:21 ET Portland Craft Chocolate Festival Returns for 2026, Cementing Portland as a Hub for Craft Chocolate and Industry Innovation
Chocolate Festival and Founder and CEO of Ranger Chocolate Co. "There's something special about the Pacific Northwest food community — it's part of our DNA: we craft, share, and create meaningful experiences for the people around us. This festival builds on that spirit, and I'm excited to help shape what
More news about: Ranger Chocolate Co.
Apr 16, 2026, 10:04 ET Face Reality® Opens First Flagship Clinic and Retail Destination in San Ramon, California
experience strategies that can be shared with Face Reality's professional partners nationwide."The clinic is an integral part of our brand DNA, and this expansion marks an important milestone as we secure our position as an acne authority," said Jeremy Soine, Chief Executive Officer at Face
More news about: Face Reality
Apr 16, 2026, 10:00 ET Blacksmith Medicines Announces Presentation at AACR Annual Meeting 2026
announced the company will present data on its oncology program targeting flap endonuclease 1 (FEN1), a structure-specific metallonuclease that cleaves 5' DNA flaps during replication and repair, at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22 at the San
More news about: Blacksmith Medicines
Apr 16, 2026, 09:15 ET DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
as human papillomavirus (HPV), can drive cancer development by disrupting normal cellular control mechanisms, sometimes through integration of viral DNA into the host genome. In internal tests, v4.5 detected 100% of expected oncoviruses and identified 18 additional oncoviruses, showcasing the software's
More news about: Illumina, Inc.
Apr 16, 2026, 09:00 ET Precision Diagnostics Publishes Groundbreaking Whitepaper on DNA-Based Urine Specimen Verification, Advancing Accuracy and Patient Experience in Toxicology Testing
of its latest whitepaper, "Use of Short Tandem Repeats (STR) for the Identification and Verification of Urine Specimens," introducing a novel, DNA-based approach to specimen authentication that is transforming the standard of care in urine drug testing.
More news about: Precision Diagnostics
Apr 16, 2026, 09:00 ET City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers
advanced cancer research and treatment organizations in the United States, is implementing Haystack MRD®, a highly accurate circulating-tumor DNA (ctDNA) minimal residual disease (MRD) test, for clinical trial participants with solid tumor cancers to help guide disease management for patients being
More news about: Quest Diagnostics
Apr 16, 2026, 09:00 ET Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.
diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Apr 16, 2026, 08:30 ET Lagunitas Teams Up with Pinter to Bring Iconic Beers to Home Brewers' Hands
behind reimagining its most iconic recipes at home."Lagunitas started as a homebrew, and that hands-on, experimental spirit has been part of our DNA ever since," said Hannah Dray, Chief Marketing Officer at Lagunitas. "Partnering with Pinter brings that story full circle, giving people the chance
More news about: Pinter
Apr 16, 2026, 08:28 ET HAVE A PUFFY* SUMMER
*Light, Layered and Unmistakably Moncler. Puffy Summer is more than a season. It's the essence of Moncler's DNA, evolved for lighter, brighter days outdoors – captured in a global campaign starring Jamie Dornan. MILAN,
More news about: Moncler
Apr 16, 2026, 08:00 ET Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that
More news about: Acurx Pharmaceuticals, Inc.
Apr 16, 2026, 08:00 ET Mount Students Compete in Annual Robert 'Bob' Fram CSI Challenge
preservation, written case documentation, witness interviewing, critical thinking, and team coordination. Participants conducted a full investigation, including DNA swabbing, latent fingerprint collection, blood evidence recovery, crime scene sketching and photography, and witness interviews, culminating in a comprehensive
More news about: Mount St. Mary's University
Apr 16, 2026, 08:00 ET Introducing Convida: A Bold, Flavor-Forward Wine Brand Inspired by Latino Culture and the Joy of Coming Together
Vineyard, and Frank Family Vineyards.The company employs a global team of approximately 2,500 people, with its culture best expressed by the 'TWE DNA' – enabling team members to be courageous, bring their whole selves to work, and deliver together. Media Contact: Haley Silvers,
More news about: Treasury Wine Estates
Apr 15, 2026, 16:20 ET Last Call for Alcohol? How America Is Trading Its Drinks for Cannabis -- Just in Time for 4/20
authentic experiences. The Meowzers collab exists because that overlap is real."The cannabis and craft beer communities share the same DNA — curiosity, craft, local loyalty, and a love of complexity. The Meowzers collab is our way of celebrating that, for the third year running."—
More news about: Native Sun
Apr 15, 2026, 15:26 ET Seragon Publishes Data for Longevity Drug SRN-901 Showing Significant Lifespan and Healthspan Extension
Pathways: Transcriptomic analyses revealed that SRN-901 modulates gene expression across pathways implicated in aging biology. Pathways related to DNA repair were upregulated in the SRN-901 treated mice. Conversely, pathways related to apoptosis, inflammatory response, reactive oxygen species, and mTORC1
More news about: Seragon Biosciences
Apr 15, 2026, 15:00 ET Perceptive Discovery Announces Strategic Partnership with MH3D and Launch of α-Sight™ to Advance Alpha Radiopharmaceutical Imaging
provider, while collaborating on product enhancements and expanding isotope imaging datasets."At Perceptive Discovery, nuclear medicine is in our DNA," said Ben Murphy, CEO of Perceptive Discovery. "By combining MH3D's innovative imaging technology with our scientific and analytical expertise, α-Sight™
More news about: Perceptive Discovery
Apr 15, 2026, 14:45 ET Manduka Expands Beyond the Yoga Studio with the Launch of the P/ROX™ Hybrid Fitness Mat
our community has trusted for nearly 30 years into the broader world of hybrid training," said James Appleby, President.The P/ROX carries the DNA of Manduka's legendary PRO, engineered with a new coated surface construction that delivers extreme durability against footwear, jump rope, and everyday
More news about: Manduka
Apr 15, 2026, 14:09 ET Manduka Expands Beyond the Yoga Studio with the Launch of the P/ROX™ Hybrid Fitness Mat
our community has trusted for nearly 30 years into the broader world of hybrid training," said James Appleby, President.The P/ROX carries the DNA of Manduka's legendary PRO, engineered with a new coated surface construction that delivers extreme durability against footwear, jump rope, and everyday
More news about: Manduka
Apr 15, 2026, 13:33 ET TEDCO's Maryland Innovation Initiative Announces More Than $2.1M to Latest Awardees
Qualifying Universities. The two awardees for the July 2025 cycles include:Nuquantic, LLC - eDNA'S CRABS: Environmental DNA System for concentrated recovery of aquatic biological samples; Johns Hopkins University; received $300,000Aletira Therapeutics,
More news about: TEDCO
Apr 15, 2026, 11:03 ET Clarins Unveils Double Serum Foundation: A Revolutionary Fusion of Skincare And Makeup
is glowy +54%⁴ Consumers also reported smoother, more refined skin (-52% visible wrinkles and pores).Plant-Powered Formula, True To Clarins DNA Enriched with 87% skincare ingredients, this breakthrough foundation is powered by 9 plant extracts and 5 active molecules. At the heart of
More news about: Clarins USA
Apr 15, 2026, 08:30 ET Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients
site activation into a single workflow. Every patient whose tumor specimen is sent to Caris receives profiling through Whole Exome Sequencing (WES) of DNA, Whole Transcriptome Sequencing (WTS) of RNA and immunohistochemistry (IHC) analysis of proteins, covering more than 23,000 genes.A proprietary
More news about: Caris Life Sciences
Apr 15, 2026, 08:00 ET PrecisionLife and Ovation ink collaboration agreement to launch GLP-1 stratification LDT and consumer GLP-1 DNA test in H2 2026
and tirzepatide against real-world patient outcomes across independent cohorts over the next six months.The partners intend to bring a consumer DNA test to market to enable individuals to understand their likely personal safety, efficacy, and tolerability profile for GLP-1 drugs to make
More news about: PrecisionLife Ltd